Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Karen Kelly describes her thought process on which molecular markers are those clearly indicated for patients with advanced NSCLC, as well as whether smoking status factors into her approach.
[powerpress]
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.